Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

Clinical trial NCT06227026 · RECRUITING

Trial details

NCT number: NCT06227026
Sponsor: University of Utah
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Diffuse Large B Cell Lymphoma

Start date: 2024-02-20
Primary completion: 2026-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.